Kong W - Search Results

1

An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer.

Feins S, Kong W, Williams EF, Milone MC, Fraietta JA. Feins S, et al. Among authors: kong w. Am J Hematol. 2019 May;94(S1):S3-S9. doi: 10.1002/ajh.25418. Epub 2019 Feb 18. Am J Hematol. 2019. PMID: 30680780 Free article. Review.

2

Biomarkers in chimeric antigen receptor T-cell therapy.

Kong W, Lacey SF, Melenhorst JJ, Fraietta JA. Kong W, et al. Biomark Med. 2018 May;12(5):415-418. doi: 10.2217/bmm-2018-0054. Epub 2018 Apr 26. Biomark Med. 2018. PMID: 29697279 No abstract available.

3

CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy.

Salas-Mckee J, Kong W, Gladney WL, Jadlowsky JK, Plesa G, Davis MM, Fraietta JA. Salas-Mckee J, et al. Among authors: kong w. Hum Vaccin Immunother. 2019;15(5):1126-1132. doi: 10.1080/21645515.2019.1571893. Epub 2019 Apr 2. Hum Vaccin Immunother. 2019. PMID: 30735463 Free PMC article.

4

BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia.

Kong W, Dimitri A, Wang W, Jung IY, Ott CJ, Fasolino M, Wang Y, Kulikovskaya I, Gupta M, Yoder T, DeNizio JE, Everett JK, Williams EF, Xu J, Scholler J, Reich TJ, Bhoj VG, Haines KM, Maus MV, Melenhorst JJ, Young RM, Jadlowsky JK, Marcucci KT, Bradner JE, Levine BL, Porter DL, Bushman FD, Kohli RM, June CH, Davis MM, Lacey SF, Vahedi G, Fraietta JA. Kong W, et al. J Clin Invest. 2021 Aug 16;131(16):e145459. doi: 10.1172/JCI145459. J Clin Invest. 2021. PMID: 34396987 Free PMC article.

5

Joint profiling of chromatin accessibility and CAR-T integration site analysis at population and single-cell levels.

Wang W, Fasolino M, Cattau B, Goldman N, Kong W, Frederick MA, McCright SJ, Kiani K, Fraietta JA, Vahedi G. Wang W, et al. Among authors: kong w. Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5442-5452. doi: 10.1073/pnas.1919259117. Epub 2020 Feb 24. Proc Natl Acad Sci U S A. 2020. PMID: 32094195 Free PMC article.

6

Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis.

Kong W, Yen JH, Ganea D. Kong W, et al. Brain Behav Immun. 2011 Jul;25(5):872-82. doi: 10.1016/j.bbi.2010.09.012. Epub 2010 Sep 18. Brain Behav Immun. 2011. PMID: 20854895 Free PMC article.

7

The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases.

Ganea D, Hooper KM, Kong W. Ganea D, et al. Among authors: kong w. Acta Physiol (Oxf). 2015 Feb;213(2):442-52. doi: 10.1111/apha.12427. Epub 2014 Dec 11. Acta Physiol (Oxf). 2015. PMID: 25422088 Free PMC article. Review.

8

Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs.

Toscano MG, Delgado M, Kong W, Martin F, Skarica M, Ganea D. Toscano MG, et al. Among authors: kong w. Mol Ther. 2010 May;18(5):1035-45. doi: 10.1038/mt.2009.293. Epub 2010 Jan 12. Mol Ther. 2010. PMID: 20068554 Free PMC article.

9

PRL-1 PTPase expression is developmentally regulated with tissue-specific patterns in epithelial tissues.

Kong W, Swain GP, Li S, Diamond RH. Kong W, et al. Am J Physiol Gastrointest Liver Physiol. 2000 Sep;279(3):G613-21. doi: 10.1152/ajpgi.2000.279.3.G613. Am J Physiol Gastrointest Liver Physiol. 2000. PMID: 10960362 Free article.

10

Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-Maf.

Hooper KM, Kong W, Ganea D. Hooper KM, et al. Among authors: kong w. PLoS One. 2017 Jun 12;12(6):e0179184. doi: 10.1371/journal.pone.0179184. eCollection 2017. PLoS One. 2017. PMID: 28604806 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,210 results

Search Page